Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Paraesthesia, Pyrexia, Vaccination site swelling, Vaccination site urticaria
Clinical narrative: The patient also developed a cough 12 days after receiving the vaccine; tiredness; There is also a pins and needles sensation/ tingling in her feet; On day 4 have pain in bones in legs just above knee very achy and constant. After a few days the pain increased and has spread down to her feet; that was hot to the touch; muscle aches; hives around the injection site; the same injection site swollen arm; fever of 103 degrees Fahrenheit; joint aches for 4-5 days after the injection, on 19Jun2021 the patient began to experience pain in the bones of her leg just above the knee; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (There is also a pins and needles sensation/ tingling in her feet), PAIN IN EXTREMITY (On day 4 have pain in bones in legs just above knee very achy and constant. After a few days the pain increased and has spread down to her feet), VACCINATION SITE WARMTH (that was hot to the touch), COUGH (The patient also developed a cough 12 days after receiving the vaccine) and MYALGIA (muscle aches) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 009D21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included BUPROPION HYDROCHLORIDE (WELLBUTRIN) for an unknown indication.    On 15-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 15-Jun-2021, the patient experienced PAIN IN EXTREMITY (On day 4 have pain in bones in legs just above knee very achy and constant. After a few days the pain increased and has spread down to her feet), VACCINATION SITE WARMTH (that was hot to the touch), MYALGIA (muscle aches), VACCINATION SITE URTICARIA (hives around the injection site), VACCINATION SITE SWELLING (the same injection site swollen arm), PYREXIA (fever of 103 degrees Fahrenheit) and ARTHRALGIA (joint aches for 4-5 days after the injection, on 19Jun2021 the patient began to experience pain in the bones of her leg just above the knee). On 19-Jun-2021, the patient experienced PARAESTHESIA (There is also a pins and needles sensation/ tingling in her feet). On an unknown date, the patient experienced COUGH (The patient also developed a cough 12 days after receiving the vaccine) and FATIGUE (tiredness). The patient was treated with CYANOCOBALAMIN (B 12) at an unspecified dose and frequency; PARACETAMOL (TYLENOL) at an unspecified dose and frequency; NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency; DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at an unspecified dose and frequency and GABAPENTINE at an unspecified dose and frequency. At the time of the report, PARAESTHESIA (There is also a pins and needles sensation/ tingling in her feet), PAIN IN EXTREMITY (On day 4 have pain in bones in legs just above knee very achy and constant. After a few days the pain increased and has spread down to her feet), VACCINATION SITE WARMTH (that was hot to the touch), COUGH (The patient also developed a cough 12 days after receiving the vaccine), MYALGIA (muscle aches), FATIGUE (tiredness), VACCINATION SITE URTICARIA (hives around the injection site), VACCINATION SITE SWELLING (the same injection site swollen arm), PYREXIA (fever of 103 degrees Fahrenheit) and ARTHRALGIA (joint aches for 4-5 days after the injection, on 19Jun2021 the patient began to experience pain in the bones of her leg just above the knee) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 15-Jun-2021, Body temperature: 103 degrees fahrenheit (High) 103 degrees Fahrenheit.         Additional treatment information included Motrin, Perkiest and non drug treatment included Ice packs, Heat packs and Rest exercise.   This case was linked to MOD-2021-250496 (Patient Link).; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.